Position in NKTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$341,889
+$338,989 QoQ
Shares Held
120,809
+5688.6% QoQ
Ownership
0.169%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#43
of 136 holders
Holding Since
Mar 2021
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NKTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Qube Research & Technologies Ltd holds $2,443,042,063 across 169 Biotechnology names. NKTX ranks #135 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
798,715 | $240,437,176 | |
| 2 | INSM |
INSMED Inc
|
1,682,334 | $179,370,451 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
221,607 | $138,180,828 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
3,454,496 | $122,254,613 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
426,336 | $104,354,262 | |
| 6 | APGE |
Apogee Therapeutics, Inc.
|
659,678 | $87,559,060 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
1,443,230 | $81,989,896 | |
| 8 | RPRX |
Royalty Pharma plc
|
1,412,112 | $79,177,119 |
All Filings in NKTX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $341,889 | 120,809 | Shares | Sole | 2026-08-14 | |
| 2023-09-30 | $2,900 | 2,087 | Shares | Sole | 2023-11-13 | |
| 2023-03-31 | $284,362 | 80,102 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,485,765 | 248,041 | Shares | Sole | 2023-02-14 | |
| 2022-06-30 | $459,166 | 37,270 | Shares | Sole | 2022-08-15 | |
| 2021-03-31 | $327,223 | 9,946 | Shares | Sole | 2021-05-14 | |
| No filing history on record for this holder in this stock. | ||||||